34 unknown. 34 Phase 3, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 34 | Unknown 34 |
| Phase 2 | 8 | Unknown 8 |
Follow Insulin Resistance: new trials by email Literature Review of Insulin Resistance trials Research Report on Insulin Resistance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Paroxetine, Placebo - Diabetes Mellitus, Type 2 | Phase 3 | Unknown | aya ramadan ashmawy sarhan | 44 | 2024-01-01 | 2024-01-12 |
| A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes Pramlintide, Lyumjev, Automated Insulin Delivery (AID) system - type1diabetes, Diabetes Mellitus, Type 1 | Phase 2 / Phase 3 | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 30 | 2023-11-30 | 2024-04-18 |
| Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility Liraglutide + Metformin, Metformin - Polycystic Ovary Syndrome, Obesity | Phase 3 | Unknown | Mỹ Đức Hospital | 188 | 2023-11-01 | 2023-10-23 |
| Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment Empagliflozin 20 mg, Empagliflozin 10 mg - Metabolic Syndrome | Phase 3 | Unknown | Collegium Medicum w Bydgoszczy | 200 | 2023-05-01 | 2024-08-27 |
| Insulin Versus Hyaluronic Acid in Management of Periodontal Defects Insulin, Hyaluronic acid - Periodontal Diseases, Periodontal Pocket | Phase 3 | Unknown | October University for Modern Sciences and Arts | 30 | 2023-01-12 | 2023-02-28 |
| Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg metformin plus 15mg pioglitazone) - Type2diabetes, Insulin Resistance | Phase 3 | Unknown | Nanjing First Hospital, Nanjing Medical University | 60 | 2022-11-01 | 2022-10-24 |
| Effect of Triticum Aestivum vs Placebo on Metabolic Profile Components and Insulin Sensitivity in Patients With Obesity Triticum Aestivum, Placebo (calcined magnesia) - Obesity, Drug Effect | Phase 3 | Unknown | Coordinación de Investigación en Salud, Mexico | 36 | 2022-07-14 | 2024-07-15 |
| Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. Berberine, Placebo - Metabolic Syndrome, HIV-1-infection | Phase 3 | Unknown | Hospital Civil de Guadalajara | 40 | 2021-04-01 | 2021-04-26 |
| The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation and Oxidative Stress Parameters and Faecal Microbiota in Patients With Depression Depending on Metabolic Syndrome Comorbidity Lactobacillus helveticus Rosell®-52, Bifidobacterium longum Rosell®-175, placebo - Depressive Disorder, Depression | Phase 3 | Unknown | Medical University of Lodz | 200 | 2020-12-17 | 2021-02-16 |
| Dapagliflozin Effect in Cognitive Impairment in Stroke Trial Dapagliflozin 10mg Tab, Statins (Cardiovascular Agents), Platelet Antiaggregant - Stroke, Ischemic, Mild Cognitive Impairment | Phase 2 / Phase 3 | Unknown | Jaime Daniel Mondragon | 270 | 2020-08-01 | 2022-10-04 |
| A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 ) Empagliflozin Tablets - Insulin Resistance - Type A, Insulin Resistance - Type B | Phase 3 | Unknown | Kobe University | 8 | 2020-02-01 | 2021-06-03 |
| A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance Empagliflozin Tablets - Insulin Resistance - Type A, Insulin Resistance - Type B | Phase 3 | Unknown | Kobe University | 8 | 2019-09-01 | 2021-03-03 |
| Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes Linagliptin + metformin, Metformin - Prediabetic State, Insulin Resistance | Phase 3 | Unknown | Universidad de Guanajuato | 34 | 2019-09-01 | 2019-10-25 |
| Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes Linagliptin + metformin and Empagliflozin + metformin, Metformin - Prediabetic State, Insulin Resistance | Phase 3 | Unknown | Universidad de Guanajuato | 34 | 2019-09-01 | 2019-10-21 |
| The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters. Glycine - Metabolic Syndrome, Dyslipidemias | Phase 2 / Phase 3 | Unknown | Prof. Tony hayek MD | 50 | 2019-03-01 | 2019-02-21 |
| Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b Elbasvir/ Grazoprevir 50/100 mg fixed dose combination - Chronic Hepatitis C Genotype 1B, Metabolic Syndrome | Phase 3 | Unknown | Institute Of Cardiology & Internal Diseases, Kazakhstan | 60 | 2017-10-01 | 2017-08-07 |
| Effect of a Probiotic on Visceral Fat Accumulation Active Probiotic, Inactivated probiotic, Control - Obesity, Intra-Abdominal Fat | Phase 3 | Unknown | Biopolis S.L. | 129 | 2016-07-01 | 2016-10-03 |
| The Effects of Butyrate on Children With Obesity Butyrate, Placebo - Insulin Resistance, Obesity | Phase 2 / Phase 3 | Unknown | Federico II University | 40 | 2016-03-01 | 2016-03-30 |
| Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke Insulin Glargine, Regular Insulin - Acute Stroke, Hyperglycemia | Phase 3 | Unknown | National Taiwan University Hospital | 120 | 2015-12-01 | 2016-08-19 |
| Effects of Local Insulin on Wound Angiogenesis Insulin, Placebo - Angiogenesis | Phase 3 | Unknown | Hospital Central "Dr. Ignacio Morones Prieto" | 20 | 2014-10-01 | 2015-03-24 |
Showing 20 of 34. Sign in to see all of them.
Metabolic Syndrome (14) · Obesity (8) · Diabetes Mellitus, Type 2 (7) · Diabetes Mellitus (4) · Dyslipidemias (3) · Cardiovascular Diseases (2) · Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans (2) · Diabetes Mellitus, Lipoatrophic (2) · Diabetes Mellitus, Type 1 (2) · Hepatitis C (2) · Hypertension (2) · Inflammation (2) · Prediabetic State (2) · Anxiety Disorders (1)
Glucose Metabolism Disorders (34) · Hyperinsulinism (34) · Nutritional and Metabolic Diseases (34) · Metabolic Diseases (33) · Endocrine System Diseases (16) · Pathological Conditions, Signs and Symptoms (12) · Diabetes Mellitus (10) · Nutrition Disorders (8) · Overnutrition (8) · Overweight (8) · Signs and Symptoms (8) · Body Weight (7) · Cardiovascular Diseases (5) · Pathologic Processes (5)
Metformin (6) · Insulin (4) · empagliflozin (4) · Bromocriptine (2) · Insulin Glargine (2) · Linagliptin (2) · Pioglitazone (2) · dapagliflozin (2) · Aspirin (1) · Atorvastatin (1) · Berberine (1) · Biguanides (1) · Butyrates (1) · Cardiovascular Agents (1) · Clopidogrel (1)
Kobe University (2) · Universidad de Guanajuato (2) · All India Institute of Medical Sciences (1) · Baker Heart Research Institute (1) · Biopolis S.L. (1) · Charite University, Berlin, Germany (1) · Collegium Medicum w Bydgoszczy (1) · Coordinación de Investigación en Salud, Mexico (1) · Dow University of Health Sciences (1) · Federico II University (1) · Hospital Central "Dr. Ignacio Morones Prieto" (1) · Hospital Civil de Guadalajara (1) · IWK Health Centre (1) · Institute Of Cardiology & Internal Diseases, Kazakhstan (1) · Jaime Daniel Mondragon (1)
Mexico (5) · Australia (2) · Canada (2) · Italy (2) · Japan (2) · Poland (2) · Taiwan (2) · Austria (1) · Brazil (1) · Denmark (1) · Egypt (1) · Germany (1) · India (1) · Kazakhstan (1) · Norway (1)
Rodolfo Guardado-Mendoza, MDPhD (2) · Wataru Ogawa (2) · Ahmad Haidar, Ph.D. (1) · Ali Imran, MD, FRCPC (1) · Ayman M Arafat, Dr.med. (1) · Bernhard Ludvik, MD (1) · Frode Gallefoss, Dr. (1) · Giuseppe Derosa, MD (1) · Jacek Kubica, Prof. (1) · Jiann-Shing Jeng, MD. PhD (1) · Laurent Legault, M.D. (1)
PMID 11527911, PMID 14688154, PMID 17980364, PMID 18068166, PMID 18364705, PMID 19056992, PMID 19841045, PMID 20204386, PMID 20524974, PMID 20718771, PMID 22117618, PMID 22767467, PMID 23040716, PMID 23966238, PMID 24151290, PMID 24281606, PMID 24362411, PMID 24581574, PMID 24789668, PMID 24937541, PMID 25590214, PMID 25682903, PMID 25827058, PMID 25874236, PMID 26297500, PMID 26401593, PMID 2670645, PMID 27459230, PMID 28095900, PMID 28479118, PMID 28681988, PMID 28760517, PMID 28950419, PMID 28961722, PMID 29016744, PMID 29371333, PMID 29446769, PMID 29573529, PMID 29703793, PMID 30033227, PMID 31031702, PMID 31229399, PMID 31236801, PMID 31238940, PMID 31248555, PMID 31535829, PMID 31733195, PMID 32115470, PMID 32144994, PMID 32178931